Skip to main content
. 2023 Jun 14;2023(6):CD009300. doi: 10.1002/14651858.CD009300.pub3

3.2. Analysis.

3.2

Comparison 3: Efficacy and safety of IVT pegcetacoplan 4‐weekly versus sham for geographic atrophy (GA), Outcome 2: Extrafoveal GA lesion size change at 1 year (mm2)